Selective suppression of humoral and cellular immunity with cytosine arabinoside.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D003561:Cytarabine / Q000494:pharmacology*; D005260:Female; D006460:Hemolysin Proteins / Q000096:biosynthesis; D006462:Hemolytic Plaque Technique; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000187:drug effects*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology / Q000276:immunology
D006460:Hemolysin Proteins; D007166:Immunosuppressive Agents; D003561:Cytarabine